Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PYRROLE DERIVATIVE HAVING, AS SUBSTITUENTS, UREIDE GROUP, AMINOCARBONYL GROUP AND BICYCLIC GROUP WHICH MAY HAVE SUBSTITUENT
Document Type and Number:
WIPO Patent Application WO/2010/024227
Kind Code:
A1
Abstract:
Disclosed is a novel pyrrole derivative having, as substituents, a ureide group, an aminocarbonyl group and a bicyclic group which may have a substituent, or a salt of the derivative.  A compound represented by general formula (1) or a salt thereof has an inhibitory activity on the production of interleukin-6, and is therefore useful as a prophylactic or therapeutic agent for diseases associated with interleukin-6, inflammatory ophthalmic diseases and the like.  In the formula, R1 represents a halogen atom, a hydrogen atom, a lower alkyl group which may have a substituent, a formyl group, or a lower alkylcarbonyl group which may have a substituent; R2 represents a bicyclic hydrocarbon group which may have a substituent, or a bicyclic hetero ring group which may have a substituent; and R3 represents a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, or an acyl group.

Inventors:
KAWASHIMA KENJI (JP)
KAWASHIMA NORIKO (JP)
ENOMOTO HIROSHI (JP)
YAMAMOTO MINORU (JP)
MURAI MASAAKI (JP)
Application Number:
PCT/JP2009/064744
Publication Date:
March 04, 2010
Filing Date:
August 25, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
KAWASHIMA KENJI (JP)
KAWASHIMA NORIKO (JP)
ENOMOTO HIROSHI (JP)
YAMAMOTO MINORU (JP)
MURAI MASAAKI (JP)
International Classes:
C07D207/34; A61K31/40; A61K31/4025; A61K31/404; A61K31/428; A61K31/538; A61K31/5415; A61P27/02; A61P43/00; C07D403/04; C07D405/04; C07D409/04; C07D413/04; C07D417/04
Domestic Patent References:
WO2008087933A12008-07-24
WO2008105408A12008-09-04
WO2003086371A22003-10-23
WO2005123671A12005-12-29
Foreign References:
JP2003522766A2003-07-29
JP2004536869A2004-12-09
Other References:
PODOLIN, P.L. ET AL.: "Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IKB kinase 2, TPCA-1(2-[(aminocarbonyl)amino]-5- (4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 312, no. 1, 2005, pages 373 - 381, XP002631348
BESSATSU IGAKU NO AYUMI, JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, SUPPLEMENT
KISO KARA RINSHO OYO, CYTOKINES, 1992, pages 28 - 35
"E-Abstract", INVEST. OPHTHALMOL. VIS. SCI., vol. 47, 2006, pages 905
DIABETES. RES. CLIN. PRACT., vol. 61, 2003, pages 93 - 101
OPHTHALMOLOGY, vol. 110, 2003, pages 1690 - 1696
DATABASE REGISTER STN; accession no. 75823-41-9
J. CHEM. SOC. PERKIN TRANSACTIONS, vol. 1, no. 5, 1978, pages 483 - 497
See also references of EP 2319831A4
Attorney, Agent or Firm:
HIBI, Norihiko et al. (JP)
Norihiko Hibi (JP)
Download PDF: